Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Niche Markets and Rare Diseases: Huntington’s Disease

Three therapies, Teva’s Huntexil, Auspex’s SD-809 and Raptor’s Procysbi, will likely receive regulatory approval for Huntington’s disease in the United States and the EU5 markets... Learn More

Novel Oral Anticoagulants in Brazil and Mexico: How to Maximize Current Usage and Gain Patient Shares Over Conventional Anticoagulants

Join us live on September 10, 2014... Learn More

View Webinar schedule and archive

Search Reports


See which reports have been searched on the most.


In the Spotlight

Join us in Boston

Come join us for an exciting one-day seminar.
Hear in-depth analysis of hot topics and trends concerning global oncology while engaging directly with Decision Resources Group analysts.

View the Agenda  |  Meet our expert speakers

Recent Reports [ view all ]

  • Immunotherapy Drug Combinations: Partnering in Immuno-Oncology

    Partnership deals in immunotherapy are forming rapidly as key players identify combination treatments as the big second... Read More

  • Muscular Dystrophy

    Muscular dystrophy (MD) is associated with degeneration and weakness of affected muscles that vary with the type of... Read More

  • Consumer Digital Marketing in the United States: The Digital Health Journey and Opportunities for Pharma Marketers

    The emergence of digital resources in the healthcare system has changed the healthcare experience for U.S.... Read More

Decision Resources Group brands include: